Federal health officials say some medications being sold may not contain the same active ingredient as FDA-approved semaglutide products.
The Food and Drug Administration is warning patients about drug compounding in medications marketed for weight loss. However, the agency said it's aware of cases in which patients have received compounded versions of semaglutide. Compounding is the process of combining, mixing or altering ingredients in a drug. "Products containing these salts, such as semaglutide sodium and semaglutide acetate, have not been shown to be safe and effective," the FDA warns.
The FDA said it has received"adverse event reports" after patients used compounded semaglutide. The agency did not detail what adverse reactions the patients reported. How to know if your product is FDA-approvedOzempic, Rybelsus and Wegovy require a prescription. Websites that offer the drugs without a prescription should be a cause for concern.
The FDA says patients should also make sure their prescriptions are filled at"state-licensed pharmacies or outsourcing facilities registered with FDA." While online pharmacies may cause some concern, there are many legitimate providers. Consumers can look up which online pharmacies are licensed by going to the FDA's website.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Federal employee stops man with knife at revolving door at Dirksen Federal BuildingA man holding a knife was stopped from entering the Dirksen Federal Building after a judicial worker stuck their foot in a revolving door to stop him from getting in earlier this month.
Baca lebih lajut »
FDA issues warning about some compounded versions of semaglutide for diabetes, weight loss | CNNThe US Food and Drug Administration issued a warning Tuesday about compounded versions of the drug semaglutide, which is approved for treatment of diabetes and excess weight.
Baca lebih lajut »
When courts challenge the FDA’s authority, they put patients’ lives at riskThe entire biotechnology and pharmaceutical industry will be thrown into turmoil if judges can second-guess the scientific expertise of the US Food and Drug Administration.
Baca lebih lajut »
‘Exciting Time’: FDA Commissioner Talks AI and MisinformationShould we be worried about AI's growing influence in healthcare, and what can the FDA do about the Adderall shortage? WebMD Chief Medical Officer drjohnwhyte sat down with US_FDA Commissioner Dr. Robert M. Califf to talk about this and more. Watch here:
Baca lebih lajut »
Former Theranos CEO Elizabeth Holmes to surrender to federal prison in Texas TuesdayElizabeth Holmes is set to surrender to federal prison in Bryan, Texas on Tuesday to begin serving her sentence.
Baca lebih lajut »